Six years in storage, 'Virus' breaks free at last

A pandemic rom com held hostage by an actual pandemic finds its way to theaters
The irony wasn't lost on anyone at Monday's press conference for the romantic comedy "Virus" -- a film about a fictional pathogen that causes people to fall madly in love was itself quarantined for nearly six years, due to a real pandemic that kept people apart.
"Although there were many twists and turns leading up to the release, I'm thrilled we can finally present the film," director Kang Yi-kwan told reporters at Seoul's Yongsan CGV cinema on Monday. The film, which completed production in late 2019, became an unwitting casualty of timing when the COVID-19 pandemic made releasing a virus-themed work virtually impossible.
Its narrative centers on Taek-sun (Bae Doo-na), a disaffected translator drifting through life, who suddenly blooms after becoming infected with the "Toxovirus" -- a pathogen with a curious symptom: it induces overwhelming happiness and instant love.
The virus places her in the orbit of three men: researcher Soo-phil (Son Suk-ku), who becomes the first infected person; her childhood friend Yeon-woo (Chang Ki-ha); and the brilliant Dr. Lee Kyun (Kim Yoon-seok), the only person capable of developing a cure.
For actor Kim Yoon-seok, the unexpected delay created a surreal disconnect between filming and release. "The world changed between shooting this film and now," he reflected. "Things we imagined -- PCR tests, lab protocols, protective equipment -- suddenly became everyday reality. It felt incredibly strange to watch our fictional scenario materialize in real life."
The film represents a tonal shift for Bae, who has spent much of the past decade in darker genre pieces like "Kingdom," the zombie-historical horror series, and "Stranger," the critically acclaimed investigative thriller.
"After projects involving disasters or intense themes, I missed something soft, warm and bright," she explained. "I've always believed that making audiences happy is a major charm of movies."
Bae hesitated to categorize the film as merely a romance, though. "I'm not sure it's a love story per se," she said. "It's more about a person discovering a different side of themselves when their emotional barriers are forcibly opened."
The film marks singer-songwriter Chang Ki-ha's lead acting debut, a challenge he initially resisted. "When I first read the script, there seemed to be too many lines. I didn't think I could do it," he admitted. "Then Kim Yoon-seok called and said, 'Film people know what they're doing. We'll create the environment -- you just come and have fun.'"
Director Kang emphasized how "Virus" offers a refreshing counterpoint to typical infection film conventions. "Most virus narratives are apocalyptic, focusing on societal collapse," he noted. "We wanted to explore a virus that makes people better versions of themselves, and examine it from a personal perspective rather than a macro view of pandemic response."
For Bae, the film's theatrical release remains important despite its long delay. "We shot this specifically for the big screen," she explained. "When actors perform for the cinema, we're conscious of how even subtle expressions will read on a large screen.
"Honestly, I wouldn't say you absolutely must watch it in theaters -- it would work anywhere -- but those small details and nuances we crafted specifically for cinema viewing might get lost on smaller devices."
Kim echoed this sentiment in more philosophical terms: "The cinema is another kind of public square. It's where unconnected strangers focus collectively on one experience, creating energy you can't replicate at home."
"Virus" opens nationwide on May 7.

Try Our AI Features

Explore what Daily8 AI can do for you:

Learn with AIFact CheckingText to SpeechAI Summary

Related Articles

Korea Herald

3 days ago

• Korea Herald

1Verse, K-pop group with North Korean defectors, to debut in July

The five-member group to hold debut showcase July 18 Another new K-pop group is set to debut, with a powerful story and a global lineup. K-pop agency Singing Beetle has announced the debut of 1Verse, a five-member multinational boy band, with a showcase scheduled for July 18. The event will be livestreamed for fans around the world. The group includes Hyuk and Seok; both were born in North Korea and later defected to South Korea. Japanese member Aito and Chinese-American Kenny joined the team followed by Nathan, a Laotian-Thai American who became the final member to join in December 2024, completing the five-member lineup. In preparation for their debut, the members have undergone extensive artist training and spent time bridging their cultural and personal backgrounds. They practice each other's languages and engage in daily conversations to build mutual understanding and strong team chemistry, according to the company. The mastermind behind the group is Cho Michelle, founder of Singing Beetle and a producer who previously worked in A&R at K-pop powerhouse SM Entertainment, where she contributed to projects that have collectively sold over 8 million albums. The group name, 1Verse, reflects the idea that each member brings their unique 'verse' to form a unified 'universe' of stories and identity. The members have steadily introduced themselves through social media and YouTube, sharing their vocal and dance training journey, and building a solid fanbase even before their official debut. On Wednesday, the group further proved its predebut popularity by revealing its official fandom name — 5Tarz — via YouTube.

Korea Herald

3 days ago

• Korea Herald

K-drama industry stands at crossroads: experts

Symbiotic relationship needed for global streaming services, Korean production bodies The Korean drama industry stands at a critical juncture, as experts and industry leaders call for reforms focused on cultivating balanced partnerships with global streaming platforms and safeguarding Korean production companies' IP rights to preserve the nation's cultural influence. At a forum hosted by the Korea Creative Content Agency, leading experts, including professors of media communications and heads of production studios, gathered to discuss the next phase of Korea's content industry. Hong Seong-chang, the head of Studio S, the drama production subsidiary of SBS, emphasized the need for a symbiotic partnership between Korean studios and international streaming services. Stressing that Korean studios should become more than mere subcontractors, he likened the ideal relationship to that between a crocodile and a plover bird -- mutually beneficial. 'The influence of investors is inevitably strong. (Global streaming services) may have requests, for example, preferring certain genres or wanting dramas to be produced in a particular creative direction," he said, during a forum held in Jung-gu, Seoul, on Thursday. "But in truth, there's only one reason Hallyu (Korean Wave) has grown as it has: because we've consistently created content that resonates with Korean audiences. That's what allowed our shows to gain popularity globally. If we had made dramas tailored to the tastes of global viewers from the start, I don't believe Hallyu would have become what it is today," said Hong. 'This is something even global streaming services can't help but acknowledge. We understand best what makes Korean content compelling, and that's something they recognize as well. Moving forward, the ideal strategy is to establish a mutually respectful relationship -- like that of a crocodile and a plover bird.' Amid skyrocketing production fees and fewer shows being made, partially due to Netflix's foray into the Korean drama landscape, Korea Drama Production Association Secretary-General Bae Dae-sik highlighted the industry's precarious state and the critical importance of intellectual property rights. 'The theme of this forum is the next strategy in the global streaming war, and the reason this topic emerged is because the (Korean) drama industry is on the verge of collapse," said Bae. "When producing Netflix originals, handing over IP ownership to Netflix is not something that should be taken lightly. Without retaining IP, hits like 'Squid Game' or 'When Life Gives You Tangerines' end up benefiting Netflix far more than us," said Bae, stressing that the new administration must develop concrete policies and systems to ensure production companies can retain IP. Bae also proposed the establishment of a dedicated professional institution focused exclusively on broadcasting and video content promotion, separate from the current KOCCA. Pointing out that the Korean drama industry's annual production budget —estimated at around 3 trillion won ($2.1 billion) — far exceeds that of the film sector, which has its own institution, he stressed the urgent need for specialized institutional support to help the crumbling industry.

Korea Herald

5 days ago

• Korea Herald

[Bio USA] SK Biopharmaceuticals teams up with PhnyX Lab to boost AI-based drug development

BOSTON -- SK Biopharmaceuticals announced Tuesday that it had signed a mutual strategic business agreement with AI startup PhnyX Lab during the Bio USA 2025 convention held in Boston, aiming to establish an AI-powered drug development framework. Through the agreement, the two companies will co-develop a customized solution that automates key processes in drug development such as literature searches, data analysis and document generation, using PhnyX Lab's proprietary generative AI platform Cheiron. The collaboration will especially focus on automating regulatory documentation required for clinical trial initiation, expediting what SK Biopharmaceuticals calls a "full-scale AI transformation" of its drug development workflow. The company expects this shift to significantly enhance R&D productivity while dramatically reducing the time and cost associated with drug development and approval. "Pharmaceutical and biotech industries face significant challenges in digital transformation due to their complex workflows and heavy regulation," said Bae Min-seok, CEO of PhnyX Lab. 'The partnership demonstrates that generative AI solutions can be effectively applied in real-world settings to improve both efficiency and accuracy in pharmaceutical operations.' As Cheiron is an end-to-end AI solution tailored for the pharmaceutical and biotech sector, the system also connects with official databases from regulatory bodies such as the US FDA and Korea's Ministry of Food and Drug Safety, as well as the Medical Subject Headings (MeSH) classification system, to deliver high accuracy and practical utility. 'AI is no longer a choice, but a core capability in drug development,' said Lee Dong-hoon, CEO of SK Biopharmaceuticals. 'By partnering with PhnyX Lab, we plan to further embed AI into every stage of our drug development process and strengthen our competitiveness in the global market.' SK Biopharmaceuticals has already been utilizing its in-house AI platform Huble in the early stages of drug development, particularly in analyzing disease-causing genes and proteins and identifying drug candidates. Through the new collaboration, the company plans to expand the application of AI across its operations to maximize productivity.